Orange Book product · Brand (NDA)
ADEMPAS
RIOCIGUAT
At a glance
Oct 08, 2013
Approved
Brand (NDA)
Application
AB
TE code
7
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 08, 2013
12 yr 11 mo ago
Today
Patent 7173037 expires
Listed drug substance patent expiration.
Dec 04, 2026
in 6 mo
Patent 10662188 expires
Listed drug substance patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Patent 10662188 expires
Listed drug substance patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Patent 11203593 expires
Listed drug substance patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Patent 11203593 expires
Listed drug substance patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Patent 12503469 expires
Listed drug product patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Patent 12503469 expires
Listed drug product patent expiration.
Feb 18, 2034
in 7 yr 9 mo
Pharmaceutical detail
Active ingredient
RIOCIGUAT
Strength
0.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 204819
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (7)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7173037 | Dec 04, 2026 | in 6 mo | SubstanceProduct |
| 10662188 | Feb 18, 2034 | in 7 yr 9 mo | SubstanceProductU-2834 |
| 10662188 | Feb 18, 2034 | in 7 yr 9 mo | SubstanceProductU-2835 |
| 11203593 | Feb 18, 2034 | in 7 yr 9 mo | SubstanceProductU-2834 |
| 11203593 | Feb 18, 2034 | in 7 yr 9 mo | SubstanceProductU-2835 |
| 12503469 | Feb 18, 2034 | in 7 yr 9 mo | ProductU-2834 |
| 12503469 | Feb 18, 2034 | in 7 yr 9 mo | ProductU-2835 |
